Evaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair Loss

NCT07358403 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2026-01-26

No results posted yet for this study

Summary

The goal of this study was to learn if dietary supplement in capsules and drinkable works to help hair loss in volunteers with chronic telogen effluvium and androgenetic alopecia and learn about its safety. The main questions it aims to answer are:

* Does dietary supplement in capsules and drinkable reduces hair loss in women and men suffering from chronic telogen effluvium or androgenetic alopecia?
* Were the products well accepted by the subjects from their´s perspective? Researchers will compare dietary supplement in capsules and drinkable to a placebo (a look-alike substance that contains no active ingredients) to see if dietary supplements works to reduce hair loss.

Participants will:

* Take assigned diatry supplement in capsule or drinkable or a placebo every day for 6 months
* Visit the study facility once every 3 months for evaulations
* Keep a diary of the product use

Conditions

  • Androgenetic Alopecia (AGA)
  • Chronic Telogen Effluvium

Interventions

DIETARY_SUPPLEMENT

Dietary supplement capsule use for hair loss

Dietary supplement capsule use for hair loss, once a day during 6 months.

DIETARY_SUPPLEMENT

Dietary supplement capsule placebo use for hair loss

Dietary supplement capsule placebo use for hair loss, once a day during 6 months.

DIETARY_SUPPLEMENT

Dietary supplement drinklable use for hair loss

Dietary supplement drinklable use for hair loss, once a day during 6 months.

DIETARY_SUPPLEMENT

Dietary supplement drinklable placebo

Dietary supplement drinklable placebo use for hair loss, once a day during 6 months.

Sponsors & Collaborators

  • Lacer S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
62 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-04
Primary Completion
2025-09-26
Completion
2025-09-26

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07358403 on ClinicalTrials.gov